<DOC>
	<DOCNO>NCT02045550</DOCNO>
	<brief_summary>To evaluate effect prophylactical therapy cough medicine contain ivy leaf dry extract frequency recurrent wheezy bronchitis toddler , duration bronchitis episode , severity additional drug demand . A prolonged asymptomatic episode wheezy bronchitis due therapy assume .</brief_summary>
	<brief_title>Tolerance Effect Prophylactical Treatment With Ivy Leaves Dry Extract Recurrent Wheezy Bronchitis</brief_title>
	<detailed_description />
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Asthma</mesh_term>
	<criteria>1 . Medical diagnosis â‰¥3 episodes wheezy bronchitis within previous 12 month 2 . Children age 1 3 year ( girl boys ) 3 . Signed Informed Consent legal guardian participate trial write verbal briefing Investigator 4 . No allergic sensitization 5 . Allowance contact family pediatrician medical history wheezy bronchitis episodes 1 . Anamnestically know intolerance/allergy one drug apply ingredient drug similar chemical structure 2 . Participation patient another clinical trial within last four week enrollment trial 3 . Evidence suggest patient legal representative likely follow trial protocol ( e.g . lack compliance ) 4 . Inability document symptom symptom log book questionnaire ; inability take trial medication properly 5 . Any regular therapy except Vitamin D Fluoride 6 . Chronic illness different aetiology 7 . Premature birth diagnosis bronchopulmonary dysplasia 8 . Gastrooesophageal reflux 9 . Hereditary fructose intolerance</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>